AMGN:NSD-Amgen Inc (USD)

COMMON STOCK | Drug Manufacturers - General |

Last Closing

USD 321.66

Change

0.00 (0.00)%

Market Cap

USD 172.84B

Volume

1.55M

Analyst Target

USD 262.76
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California. Address: One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-20 )

Largest Industry Peers for Drug Manufacturers - General

Symbol Name Price(Change) Market Cap
AZN AstraZeneca PLC ADR

N/A

USD 242.65B
SNY Sanofi ADR

N/A

USD 137.72B
GILD Gilead Sciences Inc

N/A

USD 105.89B
BIIB Biogen Inc

N/A

USD 27.90B
GRFS Grifols SA ADR

N/A

USD 6.66B
AMRN Amarin Corporation PLC

N/A

USD 0.24B
MIRA MIRA Pharmaceuticals, Inc. Com..

N/A

USD 0.02B
SCLX Scilex Holding Company

N/A

N/A
SCLXW Scilex Holding Company

N/A

N/A

ETFs Containing AMGN

BTEC:SW iShares Nasdaq US Biotech.. 7.89 % 0.00 %

N/A

N/A
UBIO 6.41 % 0.95 %

N/A

N/A
MEDX Horizon Kinetics Medical .. 5.91 % 0.00 %

N/A

N/A
LIFE-B:CA Evolve Global Healthcare .. 5.45 % 0.00 %

N/A

N/A
ZWA:CA BMO Covered Call Dow Jone.. 5.39 % 0.72 %

N/A

CAD 0.21B
ZDJ:CA BMO Dow Jones Industrial .. 5.33 % 0.26 %

N/A

CAD 0.43B
1546:TSE NEXT FUNDS DJIA (Yen-UnHe.. 5.21 % 0.00 %

N/A

USD 19.52B
THNR Amplify ETF Trust 5.08 % 0.00 %

N/A

USD 4.76M
ZWHC:CA BMO Covered Call Health C.. 5.07 % 0.00 %

N/A

N/A
DJIA Global X Dow 30 Covered C.. 5.04 % 0.00 %

N/A

USD 0.09B
CSINDU:SW iShares VII PLC - iShares.. 4.99 % 0.00 %

N/A

USD 1.25B
NDJI 4.95 % 0.00 %

N/A

N/A
LIFE-U:CA Evolve Global Healthcare .. 4.94 % 0.00 %

N/A

N/A
CIND:LSE iShares VII PLC - iShares.. 4.89 % 0.00 %

N/A

USD 1.25B
DIVO Amplify CWP Enhanced Divi.. 4.73 % 0.94 %

N/A

USD 3.69B
YALL God Bless America ETF 4.70 % 0.00 %

N/A

N/A
DOGG 4.46 % 0.00 %

N/A

N/A
GDOC Goldman Sachs ETF Trust 4.44 % 0.00 %

N/A

USD 0.02B
CBUF:F iShares V Public Limited .. 4.40 % 0.00 %

N/A

N/A
WHCS:SW iShares MSCI World Health.. 4.21 % 0.00 %

N/A

N/A
XDG3:XETRA Xtrackers MSCI Global SDG.. 4.20 % 0.00 %

N/A

USD 0.15B
CBUF:XETRA iShares MSCI World Health.. 4.17 % 0.00 %

N/A

USD 1.13B
SCHD Schwab U.S. Dividend Equi.. 3.80 % 0.07 %

N/A

USD 64.18B
FTXH First Trust Nasdaq Pharma.. 3.65 % 0.60 %

N/A

USD 0.02B
ESGI:AU VanEck MSCI International.. 3.51 % 0.00 %

N/A

USD 0.19B
WH2E:XETRA Invesco Markets II plc - .. 3.35 % 0.00 %

N/A

USD 0.08B
OZEM Roundhill GLP-1 & Weight .. 3.26 % 0.00 %

N/A

N/A
FDV First Trust Capital Stren.. 3.17 % 0.00 %

N/A

N/A
IUHC:SW iShares S&P 500 Health Ca.. 3.12 % 0.00 %

N/A

N/A
GXLV:LSE SPDR® S&P® U.S. Health .. 3.11 % 0.00 %

N/A

N/A
IUHC:LSE iShares S&P 500 USD Healt.. 3.08 % 0.00 %

N/A

USD 2.74B
QDVG:XETRA iShares S&P 500 Health Ca.. 3.08 % 0.00 %

N/A

USD 2.05B
XLV Health Care Select Sector.. 3.07 % 0.13 %

N/A

USD 41.35B
ZPDH:XETRA SPDR S&P U.S. Health Care.. 3.06 % 0.00 %

N/A

USD 0.40B
SXLV:SW SPDR S&P U.S. Health Care.. 3.06 % 0.00 %

N/A

N/A
XUHC:SW Xtrackers MSCI USA Health.. 2.98 % 0.00 %

N/A

USD 0.67B
HEAL:CA 2.96 % 0.00 %

N/A

N/A
XUHC:XETRA Xtrackers MSCI USA Health.. 2.95 % 0.00 %

N/A

USD 0.85B
NZRO 2.90 % 0.00 %

N/A

N/A
FHLC Fidelity® MSCI Health Ca.. 2.70 % 0.08 %

N/A

USD 2.95B
UDOW ProShares UltraPro Dow30 2.49 % 0.95 %

N/A

USD 0.69B
UVDV 2.35 % 0.00 %

N/A

N/A
CURE Direxion Daily Healthcare.. 2.16 % 1.06 %

N/A

USD 0.18B
USRI:LSE 1.80 % 0.00 %

N/A

N/A
DSTL Distillate US Fundamental.. 1.77 % 0.00 %

N/A

USD 2.11B
ZHU:CA BMO Equal Weight US Healt.. 1.76 % 0.00 %

N/A

CAD 0.01B
ZUH:CA BMO Equal Weight US Healt.. 1.76 % 0.39 %

N/A

CAD 0.28B
XLVE:CA Mulvihill U.S. Health Car.. 1.72 % 0.00 %

N/A

N/A
ZDY.U:CA 1.63 % 0.33 %

N/A

N/A
HYLG Global X Funds - Global X.. 1.45 % 0.00 %

N/A

N/A
LESW:LSE 1.25 % 0.00 %

N/A

N/A
TQGD:CA TD Q Global Dividend ETF 1.22 % 0.00 %

N/A

CAD 0.19B
UEFY:XETRA UBS - SBI Foreign AAA-BBB.. 1.09 % 0.00 %

N/A

USD 0.45B
SF1CHA:SW 1.09 % 0.00 %

N/A

N/A
F1ESG:SW UBS(Lux)Fund Solutions .. 1.09 % 0.00 %

N/A

N/A
BBH VanEck Biotech ETF 0.00 % 0.35 %

N/A

USD 0.45B
BIB ProShares Ultra Nasdaq Bi.. 0.00 % 0.95 %

N/A

USD 0.09B
BIS ProShares UltraShort Nasd.. 0.00 % 0.95 %

N/A

USD 3.33M
DDM ProShares Ultra Dow30 0.00 % 0.95 %

N/A

N/A
DEW WisdomTree Global High Di.. 0.00 % 0.58 %

N/A

N/A
DIA SPDR Dow Jones Industrial.. 0.00 % 0.17 %

N/A

N/A
DJD Invesco Dow Jones Industr.. 0.00 % 0.09 %

N/A

N/A
FBT First Trust NYSE Arca Bio.. 0.00 % 0.57 %

N/A

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

N/A

USD 7.45B
IYH iShares U.S. Healthcare E.. 0.00 % 0.43 %

N/A

N/A
LABS 0.00 % 0.45 %

N/A

N/A
LNGR 0.00 % 0.50 %

N/A

N/A
PBE Invesco Dynamic Biotechno.. 0.00 % 0.57 %

N/A

N/A
HONR 0.00 % 0.65 %

N/A

N/A
VSL 0.00 % 0.65 %

N/A

N/A
BTEC:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
BTEK:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
BTEE:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

N/A

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

N/A

N/A
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

N/A

N/A
SICK 0.00 % 0.95 %

N/A

N/A
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

N/A

N/A
XBI SPDR® S&P Biotech ETF 0.00 % 0.35 %

N/A

N/A
ZBIO Zenas BioPharma, Inc. Com.. 0.00 % 0.95 %

N/A

N/A
HHL:CA Harvest Healthcare Leader.. 0.00 % 1.15 %

N/A

N/A
DRDR:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

N/A
HEAL:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

N/A
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.00 %

N/A

N/A
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

N/A

N/A
VMVL:LSE 0.00 % 0.00 %

N/A

N/A
WQDS:LSE iShares MSCI World Qualit.. 0.00 % 0.00 %

N/A

N/A
WQDV:LSE iShares MSCI World Qualit.. 0.00 % 0.00 %

N/A

N/A
XLDX:LSE Xtrackers LevDAX Daily Sw.. 0.00 % 0.00 %

N/A

N/A
XSHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

N/A

USD 0.67B
XSPD:LSE Xtrackers - S&P 500 Inver.. 0.00 % 0.00 %

N/A

USD 0.15B
XSPS:LSE Xtrackers S&P 500 Inverse.. 0.00 % 0.00 %

N/A

USD 0.15B
XUHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

N/A

USD 0.67B
2B70:F iShares NASDAQ US Biotech.. 0.00 % 0.00 %

N/A

USD 0.52B
EXI3:F iShares Dow Jones Industr.. 0.00 % 0.00 %

N/A

N/A
GNAR:F 0.00 % 0.00 %

N/A

N/A
MJMT:F Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
QDVG:F iShares S&P 500 Health Ca.. 0.00 % 0.00 %

N/A

N/A
QDVW:F iShares MSCI World Qualit.. 0.00 % 0.00 %

N/A

N/A
SXRU:F iShares Dow Jones Indust .. 0.00 % 0.00 %

N/A

USD 1.23B
XAMB:F Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
XUHC:F Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

N/A

USD 0.85B
ZPDH:F SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

N/A

USD 0.40B
2B70:XETRA iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

USD 0.52B
DXS3:XETRA Xtrackers - S&P 500 Inver.. 0.00 % 0.00 %

N/A

USD 0.12B
EXI3:XETRA iShares Dow Jones Industr.. 0.00 % 0.00 %

N/A

USD 0.30B
GNAR:XETRA 0.00 % 0.00 %

N/A

N/A
SXRU:XETRA iShares VII PLC - iShares.. 0.00 % 0.00 %

N/A

USD 1.16B
VMVL:XETRA 0.00 % 0.00 %

N/A

N/A
NUSA:CA NBI Active U.S. Equity ET.. 0.00 % 0.00 %

N/A

CAD 0.06B
OUFH:XETRA 0.00 % 0.00 %

N/A

N/A
HLTH:AU VanEck Global Healthcare .. 0.00 % 0.00 %

N/A

USD 0.06B
ESNG 0.00 % 0.00 %

N/A

N/A
BMED BlackRock Future Health E.. 0.00 % 0.00 %

N/A

USD 4.21M
AGNG Global X Aging Population.. 0.00 % 0.00 %

N/A

USD 0.06B
IBBQ Invesco Nasdaq Biotechnol.. 0.00 % 0.00 %

N/A

USD 0.04B
WELG:XETRA Amundi S&P Global Health .. 0.00 % 0.00 %

N/A

N/A
WELS:XETRA Amundi S&P Global Health .. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - General) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.68% 90% A- 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.68% 90% A- 59% D-
Trailing 12 Months  
Capital Gain 15.37% 90% A- 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.37% 90% A- 51% F
Trailing 5 Years  
Capital Gain 57.04% 100% F 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 57.04% 100% F 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 7.43% 90% A- 60% D-
Dividend Return 10.48% 90% A- 62% D
Total Return 3.06% 60% D- 66% D+
Risk Return Profile  
Volatility (Standard Deviation) 14.42% 80% B- 83% B
Risk Adjusted Return 72.66% 90% A- 88% B+
Market Capitalization 172.84B 88% B+ 99% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.